JPT Peptide Technologies GmbH Company Profile

20:40 EDT 23rd March 2018 | BioPortfolio



Volmerstrasse 5 (UTZ)


Phone: 49-30-6392-7878
Fax: 49-30-6392-7888

News Articles [618 Associated News Articles listed on BioPortfolio]

Breakthrough for Peptide Medication: New Strategy Makes Peptide Active Agents Available Orally

Breakthrough for peptide medication - The “Holy Grail” of peptide chemistry: Making peptide active agents available orally. Peptides, short amino acid chains that control many functions in...

Researchers may have found a way to administer peptide therapies orally

Research from a team led by the Technical University of Munich (TUM) has uncovered a breakthrough in peptide chemistry that may enable the administration of peptide active agents orally.

New bioresources for plant peptide hormones using gene editing technology

(Kumamoto University) Peptide hormones are important growth regulators that play various roles in many organisms. Although the importance of genes that encode peptide hormones is broadly recognized, m...

Biologists’ new peptide could fight many cancers

MIT biologists have designed a new peptide that can disrupt a key

Novel Peptide Targets Injured Brain Tissues

A novel peptide with potential therapeutic use for the treatment of neurological disorders such as Alzheimer's disease (AD) and Parkinson's...

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

A collaboration between Bicycle Therapeutics and Cancer Research UK has yielded its first peptide to enter clinical trials for solid tumors. Bicycle Therapeutics, the pioneer of the bicyclic peptide p...

New Peptide Phenyl-Hexyl and AQ-C18 HALO Fused-Core columns

Advanced Materials Technology have launched two new advanced LC phases for your LC separation toolbox – HALO Peptide Phenyl-Hexyl and HALO AQ-C18. HALO 160 Å Peptide Phenyl-Hexyl – a...

Computational strategies overcome obstacles in peptide therapeutics development

(University of Washington Health Sciences/UW Medicine) Recently developed computational strategies could help realize the promise of peptide-based drugs. Researchers were able to sample the diverse la...

PubMed Articles [1262 Associated PubMed Articles listed on BioPortfolio]

Identification and quantification of signal peptide variants in an IgG1 monoclonal antibody produced in mammalian cell lines.

Sequence variants of a monoclonal antibody resulting from incomplete processing of signal peptide were identified and characterized using multiple mass spectrometry platforms and reverse phase chromat...

Singlet oxygen-mediated one-pot chemoselective peptide-peptide ligation.

We here describe a furan oxidation based site-specific chemical ligation approach using unprotected peptide segments. This approach involves two steps: after photooxidation of a furan-containing pepti...

Nature-Inspired Construction of Two-Dimensionally Self-Assembled Peptide on Pristine Graphene.

Peptide assemblies have received significant attention because of their important role in biology and applications in bionanotechnology. Despite recent efforts to elucidate the principles of peptide s...

Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.

DNA methylation, one of the most studied epigenetic modifications, regulates many biological processes. Dysregulation of DNA methylation is implicated in the etiology of several diseases, such as canc...

Zein nanoparticle as a novel BMP6 derived peptide carrier for enhanced osteogenic differentiation of C2C12 cells.

Zein nanoparticles as a carrier system for BMP6-derived peptide were prepared by liquid-liquid phase separation procedure and characterized with SEM, DLS, FTIR and thermogravimetric methods. After pep...

Clinical Trials [1086 Associated Clinical Trials listed on BioPortfolio]

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Immunotherapy is now considered to be one of promising approaches for treating cancer. Radiation therapy has been to be a cornerstone treatment for unresectable advanced esophageal cancer....

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

To evaluate the chemical efficacy and safety of intranasally administered peptide T on neurocognitive function in HIV seropositive individuals. Previous studies have shown that treatment ...

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

To evaluate safety and immunogenicity of 2 different HIV-1 peptide candidate vaccines, the UBI HIV-1 MN PND peptide immunogen and the UBI microparticulate monovalent HIV-1 MN branched pept...

Patient-individualized Peptide Vaccination in Combination With Lenalidomide After First Line Therapy of CLL

The aim of this study is to induce a peptide-specific immune response in chronic lymphatic leukaemia (CLL) patients by multi-peptide vaccination with a patient-individualized peptide cockt...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [1958 Associated Companies listed on BioPortfolio]

JPT Peptide Technologies GmbH


Peptide Resource Page

Welcome to the Peptide Resource Page (PRP). Founded in 2004, the PRP is designed to help researchers and educators navigate through the maze of peptide related websites. Search our pages to find pepti...

Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide rece...


AFFiRiS GmbH develops peptide-based vaccines for the treatment of Alzheimer's disease, atherosclerosis and other diseases that urgently require a medical solution. The company has established plat...

Peptide Solutions

Peptide Solutions LLC is a distribution partner for Iris Biotech GmbH in North America and is recognized as a leading supplier of reagents used in drug discovery, drug delivery an...

More Information about "JPT Peptide Technologies GmbH" on BioPortfolio

We have published hundreds of JPT Peptide Technologies GmbH news stories on BioPortfolio along with dozens of JPT Peptide Technologies GmbH Clinical Trials and PubMed Articles about JPT Peptide Technologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of JPT Peptide Technologies GmbH Companies in our database. You can also find out about relevant JPT Peptide Technologies GmbH Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record